Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Frontiers in Oncology|September 18, 2015
Disseminated Medulloblastoma in a Child with Germline BRCA2 6174delT Mutation and without Fanconi AnemiaJingying Xu, Ashley Sloane Margol, Anju Shukla, et al.
Oncotarget|September 9, 2017
Association of high microvessel α<sub>v</sub>β<sub>3</sub> and low PTEN with poor outcome in stage 3 neuroblastoma: rationale for using first in class dual PI3K/BRD4 inhibitor, SF1126Anat Erdreich-Epstein, Alok R Singh, Shweta Joshi, et al.
Frontiers in Immunology|December 6, 2021
Polyclonal Regulatory T Cell Manufacturing Under cGMP: A Decade of ExperienceJoanna Balcerek, Brian R Shy, Amy L Putnam, et al.
Annals of Translational Medicine|February 12, 2020
miR-194 suppresses epithelial-mesenchymal transition of retinal pigment epithelial cells by directly targeting ZEB1Lian Cui, Yali Lyu, Xiaoliang Jin, et al.
Cancer Research|March 5, 2015
CSF1 receptor targeting in prostate cancer reverses macrophage-mediated resistance to androgen blockade therapyJemima Escamilla, Shiruyeh Schokrpur, Connie Liu, et al.
Investigative Ophthalmology & Visual Science|April 16, 2021
Effectively Intervening Epithelial-Mesenchymal Transition of Retinal Pigment Epithelial Cells With a Combination of ROCK and TGF-β Signaling InhibitorsYi Chen, Binxin Wu, Jian Feng He, et al.
Glia|October 31, 2023
GMFB/AKT/TGF-β3 in Müller cells mediated early retinal degeneration in a streptozotocin-induced rat diabetes modelTong Zhu, Yingao Li, Lilin Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2013
PID1 (NYGGF4), a new growth-inhibitory gene in embryonal brain tumors and gliomasAnat Erdreich-Epstein, Nathan Robison, Xiuhai Ren, et al.
Oncotarget|February 2, 2015
Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic targetMelanie F Weingart, Jacquelyn J Roth, Marianne Hutt-Cabezas, et al.
Blood|April 28, 2016
Phase 1 studies of central memory-derived CD19 CAR T-cell therapy following autologous HSCT in patients with B-cell NHLXiuli Wang, Leslie L Popplewell, Jamie R Wagner, et al.
Pageof 8